CNBX
CNBX PHARMACEUTICAL INC
stockOTC
cannabics pharmaceuticals is dedicated to the development of advanced cannabinoid-based treatments and therapies. the company's main focus is the development of novel therapies and biotechnological tools aimed to providing relief from diverse ailments and treat human malignancies. these advanced tools include novel delivery systems, personalized medicine diagnostics and therapies based on cannabinoid compounds. cannabics' research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on cutting edge high through-output screening and bioinformatic tools. the company's principal product is cannabics sr, a long acting oil capsule that provides a safe, effective and reliable administration of cannabis. composed solely from food grade materials, cannabics sr 25mg delivers a steady level of beneficial effects for 10–12 hours . the once-per day oral dosing regimen offered by cannabics sr allows patients a more consistent therapeutic effect throughout the
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 3M | 0.00 | 2026-07-06 | -44.44% | 516.286 |
| 1Y | 0.00 | 2025-10-03 | -66.67% | 97.466 |
| 2Y | 0.01 | 2024-10-04 | -98.63% | — |
| 5Y | 18.36 | 2021-10-04 | -100.00% | 10.544 |
CNBX PHARMACEUTICAL INC (OTC:CNBX) stock price today is $0.00, and today's volume is 500,001. CNBX is up 0.000% today. The 30 day average volume is 4.17M. CNBX market cap is $3,111 with 31.11M shares outstanding.